Eliquis tablets 2.5 mg [treatment and prevention of recurrence of venous thromboembolism (deep venous thrombosis and pulmonary thromboembolism)] (エリキュース錠2.5mg［静脈血栓塞栓症（深部静脈血栓症および肺血栓塞栓症）の治療および再発抑制］)

Country: Japan

Language: English

Source: すりの適正使用協議会 RAD-AR Council, Japan

Active ingredient:

Apixaban

Available from:

Pfizer Pharmaceuticals Inc.

INN (International Name):

Apixaban

Pharmaceutical form:

yellow tablet, diameter: 6.0 mm, thickness: 2.7 mm, weight: 104 mg

Product summary:

Print on wrapping: (face)BMS Pfizer 2.5, 893 (back)エリキュース 2.5 mg

Patient Information leaflet

Drug Information Sheet("Kusuri-no-Shiori")
Internal
Revised: 01/2024
The information on this sheet is based on approvals granted by the
Japanese regulatory authority. Approval
details may vary by country. Medicines have adverse reactions (risks)
as well as efficacies (benefits). It is
important to minimize adverse reactions and maximize efficacy. To
obtain a better therapeutic response,
patients should understand their medication and cooperate with the
treatment.
BRAND NAME:
ELIQUIS TABLETS 2.5 MG [TREATMENT AND
PREVENTION OF RECURRENCE OF VENOUS
THROMBOEMBOLISM (DEEP VENOUS THROMBOSIS
AND PULMONARY THROMBOEMBOLISM)]
ACTIVE INGREDIENT:
Apixaban
DOSAGE FORM:
yellow tablet, diameter: 6.0 mm, thickness: 2.7 mm, weight:
104 mg
IMPRINT OR PRINT ON WRAPPING:
(face)BMS Pfizer 2.5, 893 (back)エリキュース
2.5 mg
EFFECTS OF THIS MEDICINE
This medicine inhibits Factor Xa as the convergence point of the
extrinsic and intrinsic blood
coagulation pathways, resulting in the prevention of the conversion
from prothrombin to
thrombin further downstream, and shows direct anti-coagulant effects
and indirect anti-
platelet effects.
It is usually used for treatment and prevention of recurrence of
venous thromboembolism
(deep venous thrombosis and pulmonary thromboembolism).
THE FOLLOWING PATIENTS MAY NEED TO BE CAREFUL WHEN USING THIS
MEDICINE.BE SURE TO TELL YOUR DOCTOR
AND PHARMACIST.
・If you have previously experienced any allergic reactions (itch,
rash, etc.) to any medicines
or foods.
If you have bleeding symptoms.
If you have abnormal blood clotting.
If you have liver disease with a risk of bleeding.
If you have renal failure.
If you are in the early period of post-spinal epidural anesthesia or
post-lumber puncture.
If you are scheduled to receive a surgery.
If your body weight is low.
・If you are pregnant or breastfeeding.
・If you are taking any other medicinal products. (Some medicines may
interact to enhance or
diminish medicinal effects. Beware of over-the-counter medicines and
dietary supplements
as well as othe